RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @majedalhoriby: Management of Bleeding in Patients on Oral Anticoagulants 2020 ACC Expert Consensus Decision Pathway👇 https://t.co/y0tZ…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @majedalhoriby: Management of Bleeding in Patients on Oral Anticoagulants 2020 ACC Expert Consensus Decision Pathway👇 https://t.co/y0tZ…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @majedalhoriby: Management of Bleeding in Patients on Oral Anticoagulants 2020 ACC Expert Consensus Decision Pathway👇 https://t.co/y0tZ…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @majedalhoriby: Management of Bleeding in Patients on Oral Anticoagulants 2020 ACC Expert Consensus Decision Pathway👇 https://t.co/y0tZ…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @majedalhoriby: Management of Bleeding in Patients on Oral Anticoagulants 2020 ACC Expert Consensus Decision Pathway👇 https://t.co/y0tZ…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
Management of Bleeding in Patients on Oral Anticoagulants 2020 ACC Expert Consensus Decision Pathway👇 https://t.co/y0tZK6Pvi0 https://t.co/rR4y8gpcfq
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
RT @ZHeart11768530: 🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess…
🔴 Management of Bleeding in Patients on Oral Anticoagulants: 2020 ACC Expert Consensus Decision Pathway #openaccess https://t.co/avw7ej8M8H #CardioTwitter #cardiology #CardioEd #medical #meded #medtwitter #ECG #ekg https://t.co/zaayWtkIIO
RT @cardiomet_CE: 8) In 2020 @JACC expert consensus provided a great outline on pt management for 🩸🩸. They highlight recommended #reversal…
26b) … and the ACC Expert Consensus Pathway for the Management of #OAC-Associated Bleeding 🔓 https://t.co/5qhPaQ9Ems https://t.co/LeBEXB6bsf
12b) Guidance to support either dosing option is listed below: 👉 from @neurocritical & @SCCM: https://t.co/e0eXIAmbsc 👉 from @American_Heart: 🔓https://t.co/vaHdmoyaHD 👉from @ACCinTouch: https://t.co/5qhPaQ9Ems
DOAC VKA内服中の出血への対応 https://t.co/3qHG6VMvZB
RT @cardiomet_CE: 28b) The 2020 ACC Expert Consensus Decision Pathway (🔓 https://t.co/5qhPaQ9Ems) gives preference to #andexanet, when the…
28b) The 2020 ACC Expert Consensus Decision Pathway (🔓 https://t.co/5qhPaQ9Ems) gives preference to #andexanet, when the drug is available. https://t.co/R5IzscoA3e
RT @HaseebEPHF: @JACCJournals 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants .. h…
@JACCJournals 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants .. https://t.co/Rxd293rnL4 @ESC_Journals @ACCinTouch @escardio @AHAScience @LAHRSonline1 @APHRSOfficial @HRSonline @ehj_ed @EuropaceEiC #
RT @emlitofnote: "Oh, the transparency requirements in modern medical publishing will make biased profiteering in 'guidelines' and 'expert…
RT @emlitofnote: "Oh, the transparency requirements in modern medical publishing will make biased profiteering in 'guidelines' and 'expert…
RT @emlitofnote: "Oh, the transparency requirements in modern medical publishing will make biased profiteering in 'guidelines' and 'expert…
"Oh, the transparency requirements in modern medical publishing will make biased profiteering in 'guidelines' and 'expert consensus' obsolete." Counterpoint: Anticoagulation reversal guidelines, prominently featuring Xa (recombinant), inactivated-zhzo. h
RT @cardiomet_CE: 16) @American_Heart Association 🫀 2022 Guidelines consider #Andexanet as a reasonable option in #ICH (COR: 2a, LOE: B-NR,…
16) @American_Heart Association 🫀 2022 Guidelines consider #Andexanet as a reasonable option in #ICH (COR: 2a, LOE: B-NR, 🔓https://t.co/oJVvgOWWCy). The 2020 ACC Expert Consensus Decision Pathway (🔓 https://t.co/5qhPaQ9Ems) gives preference to #Andexanet,
32) This is based on the 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants, at 🔓https://t.co/q1UdaurkTi https://t.co/JuOcT0fs6C
RT @cardiomet_CE: 10f) This is reflected in current guidelines (such as 🔓 https://t.co/q1UdaurkTi), which generally suggest use of 4F-PCCs…
10f) This is reflected in current guidelines (such as 🔓 https://t.co/q1UdaurkTi), which generally suggest use of 4F-PCCs to reverse apixaban- or rivaroxaban-associated major bleeding including #ICH, only if @andexanet is not available https://t.co/ZJaV1Fnb
RT @cardiomet_CE: 24) The 2020 @ACCinTouch Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants p…
RT @cardiomet_CE: 24) The 2020 @ACCinTouch Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants p…
24) The 2020 @ACCinTouch Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants provide solid guidance that reflect the above concepts. See Reference here: 🔓https://t.co/5qhPaQacc0 https://t.co/Q9Lx7w9uui